186 related articles for article (PubMed ID: 20175216)
21. The role of saposin C in Gaucher disease.
Tamargo RJ; Velayati A; Goldin E; Sidransky E
Mol Genet Metab; 2012 Jul; 106(3):257-63. PubMed ID: 22652185
[TBL] [Abstract][Full Text] [Related]
22. The exon 8-containing prosaposin gene splice variant is dispensable for mouse development, lysosomal function, and secretion.
Cohen T; Auerbach W; Ravid L; Bodennec J; Fein A; Futerman AH; Joyner AL; Horowitz M
Mol Cell Biol; 2005 Mar; 25(6):2431-40. PubMed ID: 15743835
[TBL] [Abstract][Full Text] [Related]
23. Targeted disruption of the mouse prosaposin gene affects the development of the prostate gland and other male reproductive organs.
Morales CR; Zhao Q; El-Alfy M; Suzuki K
J Androl; 2000; 21(6):765-75. PubMed ID: 11105903
[TBL] [Abstract][Full Text] [Related]
24. Deficiency of Glucocerebrosidase Activity beyond Gaucher Disease: PSAP and LIMP-2 Dysfunctions.
Pavan E; Peruzzo P; Cattarossi S; Bergamin N; Bordugo A; Sechi A; Scarpa M; Biasizzo J; Colucci F; Dardis A
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928321
[TBL] [Abstract][Full Text] [Related]
25. Saposin C-LBPA interaction in late-endosomes/lysosomes.
Chu Z; Witte DP; Qi X
Exp Cell Res; 2005 Feb; 303(2):300-7. PubMed ID: 15652344
[TBL] [Abstract][Full Text] [Related]
26. Late Infantile Metachromatic Leukodystrophy Due to Novel Pathogenic Variants in the PSAP Gene.
Kolnikova M; Jungova P; Skopkova M; Foltan T; Gasperikova D; Mattosova S; Chandoga J
J Mol Neurosci; 2019 Apr; 67(4):559-563. PubMed ID: 30632081
[TBL] [Abstract][Full Text] [Related]
27. [Disorders of sphingolipid activator proteins].
Suzuki Y
Nihon Rinsho; 1995 Dec; 53(12):3025-7. PubMed ID: 8577053
[TBL] [Abstract][Full Text] [Related]
28. Pathological study of mice with total deficiency of sphingolipid activator proteins (SAP knockout mice).
Oya Y; Nakayasu H; Fujita N; Suzuki K; Suzuki K
Acta Neuropathol; 1998 Jul; 96(1):29-40. PubMed ID: 9678511
[TBL] [Abstract][Full Text] [Related]
29. Conservation of expression and alternative splicing in the prosaposin gene.
Cohen T; Ravid L; Altman N; Madar-Shapiro L; Fein A; Weil M; Horowitz M
Brain Res Mol Brain Res; 2004 Oct; 129(1-2):8-19. PubMed ID: 15469878
[TBL] [Abstract][Full Text] [Related]
30. Characterization of
Sellin J; Schulze H; Paradis M; Gosejacob D; Papan C; Shevchenko A; Psathaki OE; Paululat A; Thielisch M; Sandhoff K; Hoch M
Dis Model Mech; 2017 Jun; 10(6):737-750. PubMed ID: 28389479
[TBL] [Abstract][Full Text] [Related]
31. Metachromatic leukodystrophy without arylsulfatase A deficiency: a new case of saposin-B deficiency.
Deconinck N; Messaaoui A; Ziereisen F; Kadhim H; Sznajer Y; Pelc K; Nassogne MC; Vanier MT; Dan B
Eur J Paediatr Neurol; 2008 Jan; 12(1):46-50. PubMed ID: 17616409
[TBL] [Abstract][Full Text] [Related]
32. Phenotype Expansion for Atypical Gaucher Disease Due to Homozygous Missense PSAP Variant in a Large Consanguineous Pakistani Family.
Liaqat K; Hussain S; Acharya A; Nasir A; Bharadwaj T; Ansar M; Basit S; Schrauwen I; Ahmad W; Leal SM
Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456468
[TBL] [Abstract][Full Text] [Related]
33. Variants in saposin D domain of prosaposin gene linked to Parkinson's disease.
Oji Y; Hatano T; Ueno SI; Funayama M; Ishikawa KI; Okuzumi A; Noda S; Sato S; Satake W; Toda T; Li Y; Hino-Takai T; Kakuta S; Tsunemi T; Yoshino H; Nishioka K; Hattori T; Mizutani Y; Mutoh T; Yokochi F; Ichinose Y; Koh K; Shindo K; Takiyama Y; Hamaguchi T; Yamada M; Farrer MJ; Uchiyama Y; Akamatsu W; Wu YR; Matsuda J; Hattori N
Brain; 2020 Apr; 143(4):1190-1205. PubMed ID: 32201884
[TBL] [Abstract][Full Text] [Related]
34. An Asn > Lys substitution in saposin B involving a conserved amino acidic residue and leading to the loss of the single N-glycosylation site in a patient with metachromatic leukodystrophy and normal arylsulphatase A activity.
Regis S; Filocamo M; Corsolini F; Caroli F; Keulemans JL; van Diggelen OP; Gatti R
Eur J Hum Genet; 1999; 7(2):125-30. PubMed ID: 10196694
[TBL] [Abstract][Full Text] [Related]
35. The interaction between progranulin and prosaposin is mediated by granulins and the linker region between saposin B and C.
Zhou X; Sullivan PM; Sun L; Hu F
J Neurochem; 2017 Oct; 143(2):236-243. PubMed ID: 28640985
[TBL] [Abstract][Full Text] [Related]
36. Processing of sphingolipid activator proteins and the topology of lysosomal digestion.
Sandhoff K; Kolter T
Acta Biochim Pol; 1998; 45(2):373-84. PubMed ID: 9821868
[TBL] [Abstract][Full Text] [Related]
37. Identification of prosaposin as a novel interaction partner for Rhox5.
Guo F; Huang X; Li S; Sun L; Li Y; Li H; Zhou Y; Chu Y; Zhou T
J Genet Genomics; 2007 May; 34(5):392-9. PubMed ID: 17560524
[TBL] [Abstract][Full Text] [Related]
38. A mutation within the saposin D domain in a Gaucher disease patient with normal glucocerebrosidase activity.
Diaz-Font A; Cormand B; Santamaria R; Vilageliu L; Grinberg D; Chabás A
Hum Genet; 2005 Jul; 117(2-3):275-7. PubMed ID: 15856305
[TBL] [Abstract][Full Text] [Related]
39. Conformational and amino acid residue requirements for the saposin C neuritogenic effect.
Qi X; Kondoh K; Krusling D; Kelso GJ; Leonova T; Grabowski GA
Biochemistry; 1999 May; 38(19):6284-91. PubMed ID: 10320358
[TBL] [Abstract][Full Text] [Related]
40. Distribution of prosaposin in the rat nervous system.
Hosoda Y; Miyawaki K; Saito S; Chen J; Bing X; Terashita T; Kobayashi N; Araki N; Shimokawa T; Hamada F; Sano A; Tanabe H; Matsuda S
Cell Tissue Res; 2007 Nov; 330(2):197-207. PubMed ID: 17763872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
